Point72 Asset Management L.P. 13D and 13G filings for Intercept Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:01 pm Sale |
2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Point72 Asset Management L.P. | 392,151 0.900% |
-1,968,718 (-83.39%) |
Filing |
| 2022-10-11 8:29 pm Purchase |
2022-10-03 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Point72 Asset Management L.P. | 2,360,869 5.700% |
2,360,869 (New Position) |
Filing |